In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
|Podcasts|May 13, 2022
Prioritizing American Manufacturing
Author(s)Nicholas Saraceno, Senior Editor, Julian Upton
Biopharma firm strives to deliver savings to the US healthcare system
Advertisement
David Sanders, vice president of government affairs & policy at biosimilars company Coherus BioSciences, speaks on the firm’s goal of expanding patient access to cost-effective medication, and his role with Securing America’s Medicines and Supply, a coalition of companies aiming to strengthen the security of the US medical supply chain.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: What Comes Next for the 340B Rebate Pilot
2
Supply Chain Signal: How Policy Pressures Are Converging on Pharma
3
Copeland Closes Dickson Deal to Expand Cold Chain Monitoring
4
Why Retail Pharmacy’s Trust Challenge Is Also Its Path Forward
5